Neonatal jaundice remains a significant concern in newborn care, affecting up to 60% of full-term infants. The need for accurate, non-invasive bilirubin measurement has driven medical diagnostic equipment manufacturers to develop advanced solutions. Transcutaneous bilirubinometers have emerged as a game-changing tool, allowing healthcare providers to quickly and painlessly assess jaundice levels in newborns. As the demand for these devices grows, transcutaneous bilirubinometer suppliers  are continually refining their products to meet the evolving needs of neonatal care units worldwide. The MJD-2513 Transcutaneous Jaundice Tester exemplifies this progress, offering dual-wavelength technology and portability to enhance jaundice management in various clinical settings.   Table of contents: The Role of Dual-Wavelength Technology in Accurate Bilirubin Measurement Integrating Transcutaneous Bilirubinometers into NICU Workflows How Portable Bilirubin Meters Support Home-Based N...